Which adults with differentiated thyroid cancer is Lenvatinib Eisai indicated to treat?

Lenvatinib Eisai monotherapy is indicated for adults with progressive, locally advanced or metastatic differentiated thyroid carcinoma (papillary, follicular or Hürthle cell) that is refractory to radioactive iodine.